NO971890L - Orale cyklosporinformuleringer - Google Patents

Orale cyklosporinformuleringer

Info

Publication number
NO971890L
NO971890L NO971890A NO971890A NO971890L NO 971890 L NO971890 L NO 971890L NO 971890 A NO971890 A NO 971890A NO 971890 A NO971890 A NO 971890A NO 971890 L NO971890 L NO 971890L
Authority
NO
Norway
Prior art keywords
formulations
solvent
oral cyclosporine
cyclosporine formulations
present formulations
Prior art date
Application number
NO971890A
Other languages
English (en)
Other versions
NO971890D0 (no
Inventor
Moo J Cho
Ralph E Levy
Philippe J Pouletty
H Robert Floc
Christian Merle
Original Assignee
Sangstat Medical Corp
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/519,689 external-priority patent/US5834017A/en
Priority claimed from US08/620,021 external-priority patent/US5766629A/en
Priority claimed from US08/622,516 external-priority patent/US5827822A/en
Application filed by Sangstat Medical Corp, Univ North Carolina filed Critical Sangstat Medical Corp
Publication of NO971890L publication Critical patent/NO971890L/no
Publication of NO971890D0 publication Critical patent/NO971890D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

Det blir beskrevet forbedrede orale cyklosporinformuleringer som har høy biolilgjenge- lighet og har evnen til administrering i harde kapsler eller nanopartikler. I de aktuelle formuleringene blir cyklosporin avlevert i en oralt akseptabel bærer som omfatter minste ett alkanoloppløsningsmiddel med fra 2 til 3 karbonatomer i kombinasjon med minst et ikke-ionisk overflateaktivt middel. De aktuelle formuleringene kan videre omfatte minst et kooppløsningsmiddel, der kooppløsningsmidlene som er interessante innbefatter fettsyrer og dioler De aktuelle formuleringene finner anvendelse i immun- suppressiv terapi.
NO971890A 1995-08-25 1997-04-24 Orale cyklosporinformuleringer NO971890D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/519,689 US5834017A (en) 1995-08-25 1995-08-25 Oral cyclopsporin formulations
US08/620,021 US5766629A (en) 1995-08-25 1996-03-21 Oral cyclosporin formulations
US08/622,516 US5827822A (en) 1996-03-25 1996-03-25 Cyclosporin a formulations as nanoparticles
PCT/US1996/012569 WO1997007787A1 (en) 1995-08-25 1996-07-31 Oral cyclosporin formulations

Publications (2)

Publication Number Publication Date
NO971890L true NO971890L (no) 1997-04-24
NO971890D0 NO971890D0 (no) 1997-04-24

Family

ID=27414735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971890A NO971890D0 (no) 1995-08-25 1997-04-24 Orale cyklosporinformuleringer

Country Status (27)

Country Link
EP (1) EP0789561B1 (no)
JP (1) JP3009742B2 (no)
KR (1) KR100294935B1 (no)
CN (1) CN1164828A (no)
AR (1) AR001985A1 (no)
AT (1) ATE263550T1 (no)
AU (1) AU709548B2 (no)
BG (1) BG62875B1 (no)
BR (1) BR9606603A (no)
CA (1) CA2202887A1 (no)
CZ (1) CZ124897A3 (no)
DE (2) DE69632125T2 (no)
ES (1) ES2129381T1 (no)
GE (1) GEP20012547B (no)
HK (1) HK1001956A1 (no)
HU (1) HUP9801052A3 (no)
IL (1) IL120673A0 (no)
IS (1) IS4460A (no)
MX (1) MX9702809A (no)
NO (1) NO971890D0 (no)
NZ (1) NZ313899A (no)
PL (1) PL319898A1 (no)
RO (1) RO119815B1 (no)
SI (1) SI9620014A (no)
SK (1) SK53697A3 (no)
TW (1) TW460287B (no)
WO (1) WO1997007787A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
US6657104B1 (en) 1997-10-16 2003-12-02 Texas Systems, University Of The Board Of The Regents Transgenic mouse model for cardiac hypertrophy and methods of use thereof
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
EP2586428B1 (en) 2007-04-26 2023-11-08 Sublimity Therapeutics Limited Manufacture of multiple minicapsules
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물
CN104940132B (zh) * 2015-06-05 2018-02-27 河南牧翔动物药业有限公司 一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
CA2231404C (en) * 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them

Also Published As

Publication number Publication date
JPH10509462A (ja) 1998-09-14
BG62875B1 (bg) 2000-10-31
NZ313899A (en) 2000-03-27
EP0789561A1 (en) 1997-08-20
CA2202887A1 (en) 1997-03-06
KR100294935B1 (ko) 2001-07-12
WO1997007787A1 (en) 1997-03-06
RO119815B1 (ro) 2005-04-29
PL319898A1 (en) 1997-09-01
EP0789561A4 (en) 1998-12-02
JP3009742B2 (ja) 2000-02-14
IL120673A0 (en) 1997-08-14
MX9702809A (es) 1998-02-28
BG101443A (en) 1998-03-31
KR970706803A (ko) 1997-12-01
CZ124897A3 (en) 1997-09-17
ATE263550T1 (de) 2004-04-15
CN1164828A (zh) 1997-11-12
DE69632125D1 (de) 2004-05-13
HK1001956A1 (en) 1998-07-24
DE69632125T2 (de) 2004-09-16
DE789561T1 (de) 1999-06-10
AU709548B2 (en) 1999-09-02
ES2129381T1 (es) 1999-06-16
HUP9801052A3 (en) 1998-12-28
IS4460A (is) 1997-04-08
BR9606603A (pt) 1997-09-30
EP0789561B1 (en) 2004-04-07
HUP9801052A2 (hu) 1998-09-28
GEP20012547B (en) 2001-10-25
NO971890D0 (no) 1997-04-24
SI9620014A (sl) 1998-04-30
SK53697A3 (en) 1997-10-08
AR001985A1 (es) 1998-01-07
AU6644196A (en) 1997-03-19
TW460287B (en) 2001-10-21

Similar Documents

Publication Publication Date Title
NO993096L (no) Orale cyklosporinformuleringer
NO971890L (no) Orale cyklosporinformuleringer
KR960016903A (ko) 경구용 제약 제조물
CO4930289A1 (es) Composiciones galenicas, en donde el ingrediente activo es un agente activo dificilmente soluble
ATE216590T1 (de) Arzneimittelformulierungen für il-12
NO994266D0 (no) Hydrofile binære systemer for administrasjon av cyklosporin
MY130670A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ES2154661T3 (es) Preparados liquidos que contienen cyclosporin y procedimiento para su obtencion.
AR012287A1 (es) Preparado de medicamento para la administracion peroral y uso de portadores, especialmente de polietilenglicol-660-12-hidroxiestearato yetanol o 1,2-propilenglicol
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
CA2344248A1 (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
EA200000702A1 (ru) Пролекарства ингибиторов аспартилпротеаз
DE69711637T2 (de) Aerosolformulierungen
BR9810866B1 (pt) composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
RS50373B (sr) Čvrste lipidne smeše
ATE167872T1 (de) Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen
DK1126867T3 (da) Sammensætning til forebyggelse og/eller behandling af åreforkalkning
DK1154759T3 (da) Dispergerbart koncentrat til indgift af cyclosporin
DE69710732T2 (de) Ciclosporin formulierung
EA200200415A1 (ru) Композиция фармацевтического носителя
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
WO2001022969A3 (en) Vasopressin agonist formulation and process
BG102083A (en) Compositions and methods for the detection and treatment of aids
KR960040356A (ko) 피누솔라이드의 가용화방법 및 이 방법에 의해 제조된 피누솔라이드 가용화물
ES2118033A1 (es) Formulacion farmaceutica antiinflamatoria.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application